Latest news
Loading news…
Veloxis
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Hørsholm, Hovedstaden, Denmark Founded 2002 101-250 employees For Profit
Veloxis is a speciality pharmaceutical company focused on the development and commercialization of Envarsus.
Veloxis was acquired by Asahi Kasei in 2019 for $1B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Investments
1
Monthly Visits
Available in Pro Contacts
89
Patents
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- VELO
- Exchange
- NASDAQ
- IPO date
- Nov 13, 2006
- Delisted
- Feb 24, 2020
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 17
- Active products
- 21
- Patents granted
- 7
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $855K
Investor Activity
- Investments
- 1
- Lead investments
- 1
- Portfolio orgs
- 1
Company Info
- Founded
- 2002
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company, investor
- Founders
- 1
- News articles
- 38
- HQ
- Hørsholm, Hovedstaden, Denmark
- Region
- European Union (EU), Nordic Countries, Scandinavia
- Exit date
- Nov 13, 2006
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 1.3
- Trend (90d)
- -0.2
Investments by Veloxis
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Veloxis
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Veloxis
President, CEO
Chief Scientific Officer
SVP, Global Clinical Development & Operations
89
professional contacts at Veloxis
Contact execs at Veloxis →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Veloxis
Loading news…
FAQs about Veloxis
People who checked this page also checked these
Sectors Veloxis invests & acquires in
Browse the full Acquirezy directory.